Want to see SE:QCORE full AI Analyst Report?
QCORE Stock Chart & Stats
kr0.50
-kr0.12(-3.11%)
At close: 4:00 PM EST
kr0.50
-kr0.12(-3.11%)
Day’s Range― - ―
52-Week Rangekr0.21 - kr0.58
Previous CloseN/A
Volume1.64K
Average Volume (3M)10.68K
Market Cap
kr14.59M
Enterprise Valuekr10.89M
Total Cash (Recent Filing)kr6.06M
Total Debt (Recent Filing)kr1.25M
Price to Earnings (P/E)―
Beta0.16
Next Earnings
Nov 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding42,900,500
10 Day Avg. Volume7,250
30 Day Avg. Volume10,684
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.38
Price to Sales (P/S)2.07
P/FCF Ratio-1.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low leverage reduces refinancing and solvency pressure, preserving financial flexibility while the company works to improve operations. Lower debt also limits interest burdens and leaves more capacity to direct future funding toward product development, commercial activity, or strategic priorities.
Specialized Software OfferingA focused software position in omics and high-dimensional biological data gives Qlucore a clearly defined role in research and diagnostics workflows. Specialized analytical capabilities can support customer relevance and product differentiation as data complexity increases across life-science applications.
Recent Revenue RecoveryThe return to revenue growth indicates that demand has begun to stabilize after earlier declines, providing a more constructive base for recovery. If sustained, renewed top-line momentum could improve operating leverage and help the company convert its specialized offering into a stronger earnings trajectory.
Bears Say
Persistent Cash BurnOngoing operating and free-cash-flow deficits show that the business is not currently funding itself through operations. Continued cash consumption can require external funding or balance-sheet resources, limiting strategic flexibility and making execution dependent on restoring sustainable cash generation.
Severely Negative ProfitabilityGross profit below zero means cost of revenue is exceeding sales, leaving the company without a viable current margin foundation. Persistent operating and net losses can restrict reinvestment, weaken resilience, and make revenue growth insufficient unless the cost structure improves materially.
Eroding Equity CushionThe substantial decline in equity reflects the cumulative effect of ongoing losses and reduces the capital cushion available to absorb further deterioration. Although leverage is low, continued equity erosion can constrain funding options and increase the importance of achieving profitability before resources are depleted.
QCORE FAQ
What was Qlucore AB’s price range in the past 12 months?
Qlucore AB lowest stock price was kr0.21 and its highest was kr0.58 in the past 12 months.
What is Qlucore AB’s market cap?
Qlucore AB’s market cap is kr14.59M.
When is Qlucore AB’s upcoming earnings report date?
Qlucore AB’s upcoming earnings report date is Nov 26, 2026 which is in 26 days.
How were Qlucore AB’s earnings last quarter?
Qlucore AB released its earnings results on Sep 09, 2026. The company reported -kr0.067 earnings per share for the quarter.
Is Qlucore AB overvalued?
According to Wall Street analysts Qlucore AB’s price is currently Overvalued.
Does Qlucore AB pay dividends?
Qlucore AB does not currently pay dividends.
What is Qlucore AB’s EPS estimate?
Qlucore AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qlucore AB have?
Qlucore AB has 42,900,500 shares outstanding.
What happened to Qlucore AB’s price movement after its last earnings report?
Qlucore AB reported an EPS of -kr0.067 in its last earnings report. Following the earnings report the stock price went down -3.175%.
Which hedge fund is a major shareholder of Qlucore AB?
Currently, no hedge funds are holding shares in SE:QCORE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Qlucore AB
Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bioinformatics software designed for research across various sectors such as life science, biotechnology, food, plant industries, and academia. Additionally, the company offers Qlucore Diagnostics, a specialized software platform for multi-omics companion and precision diagnostics, as well as Qlucore Insights, which facilitates the analysis of clinical data. Qlucore was established in 2007.
Technical Analysis
Precise Biometrics AB
―
AegirBio AB
―
Modelon AB
―
Vitec Software Group AB Class B
―
Carasent AB
―